Mutational Analysis of
BRCA1/2
Ki-67
NGS
hereditary breast cancer
tumor grading
Journal
Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
11
2021
accepted:
26
01
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
Germline mutations of Mutational status was assessed in a cohort of 389 BC patients, using next generation sequencing. The presence of alterations was correlated with tumor grading and proliferation index. Overall, 35 patients (9%) harbored a Our findings provide an overview about
Identifiants
pubmed: 35411189
doi: 10.2147/CMAR.S348529
pii: 348529
pmc: PMC8994564
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1341-1352Informations de copyright
© 2022 Stella et al.
Déclaration de conflit d'intérêts
Federica Martorana reports honoraria from Istituto Gentili, Lilly, Novartis, Pfizer. The other authors declare no conflicts of interest in this work.
Références
Am Soc Clin Oncol Educ Book. 2019 Jan;39:79-86
pubmed: 31099688
Cancer. 2016 Apr 15;122(8):1178-84
pubmed: 26859126
Breast Cancer Res Treat. 2012 Apr;132(3):895-915
pubmed: 22048814
Transl Oncol. 2021 Aug;14(8):101104
pubmed: 33993096
Transl Oncol. 2020 Feb;13(2):212-220
pubmed: 31869745
N Engl J Med. 2021 Feb 4;384(5):440-451
pubmed: 33471974
Ann Oncol. 2017 Aug 1;28(8):1700-1712
pubmed: 28838210
Ther Adv Med Oncol. 2020 Dec 16;12:1758835920975326
pubmed: 33403015
Mol Biol Rep. 2019 Oct;46(5):5537-5541
pubmed: 31273614
Nat Rev Cancer. 2007 Dec;7(12):937-48
pubmed: 18034184
Breast Cancer Res. 2000;2(4):307-10
pubmed: 11056688
Breast Cancer Res Treat. 2016 Sep;159(2):245-56
pubmed: 27553368
Genet Med. 2020 May;22(5):825-830
pubmed: 31911673
Genet Test Mol Biomarkers. 2009 Aug;13(4):465-9
pubmed: 19594371
Crit Rev Oncol Hematol. 2019 Mar;135:66-75
pubmed: 30819448
Ann Oncol. 2009 Jun;20(6):1143-4
pubmed: 19423647
PLoS One. 2013 May 21;8(5):e64268
pubmed: 23704984
JAMA. 2015 Apr 7;313(13):1347-61
pubmed: 25849179
Breast Cancer Res Treat. 2019 Jan;173(1):37-48
pubmed: 30267249
Lancet. 2010 Jul 24;376(9737):235-44
pubmed: 20609467
Ann Oncol. 2015 Jul;26(7):1291-9
pubmed: 25605744
Ann Oncol. 2013 Sep;24(9):2206-23
pubmed: 23917950
Breast Cancer Res. 2010;12(4):207
pubmed: 20804570
Eur J Cancer. 2021 Mar;146:30-47
pubmed: 33578357
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Cancers (Basel). 2020 May 19;12(5):
pubmed: 32438681
N Engl J Med. 2021 Feb 4;384(5):428-439
pubmed: 33471991
Genes (Basel). 2020 Dec 03;11(12):
pubmed: 33287145
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cancer Manag Res. 2019 Mar 22;11:2321-2337
pubmed: 30962720
Ann Oncol. 2009 May;20(5):874-8
pubmed: 19179552
Cancers (Basel). 2020 May 05;12(5):
pubmed: 32380732
Cancer Res Treat. 2019 Jul;51(3):941-950
pubmed: 30309222
J Cell Physiol. 2019 May;234(5):5741-5750
pubmed: 30552672
Nat Methods. 2010 Aug;7(8):575-6
pubmed: 20676075
Cancers (Basel). 2020 May 15;12(5):
pubmed: 32429297
Cancer Sci. 2020 Sep;111(9):3350-3358
pubmed: 32495382
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Hum Mutat. 2018 May;39(5):593-620
pubmed: 29446198
J Cell Mol Med. 2020 Jan;24(2):1676-1683
pubmed: 31782247
Breast Cancer Res Treat. 2015 Oct;153(3):477-91
pubmed: 26341751
Hum Mutat. 2019 Sep;40(9):1557-1578
pubmed: 31131967
J Natl Cancer Inst. 2014 Apr 28;106(5):
pubmed: 24777111
Science. 2003 Oct 24;302(5645):643-6
pubmed: 14576434
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47
pubmed: 22144499
Clin Breast Cancer. 2018 Oct;18(5):362-373.e1
pubmed: 29673794
Genet Med. 2022 Jan;24(1):119-129
pubmed: 34906479
Bioinformatics. 2019 Jun 1;35(11):1978-1980
pubmed: 30376034
Arch Gynecol Obstet. 2017 May;295(5):1227-1238
pubmed: 28324225
Breast Cancer Res Treat. 2006 Nov;100(1):83-91
pubmed: 16847550
J Natl Cancer Inst. 2021 Jul 1;113(7):808-819
pubmed: 33369635
EPMA J. 2010 Sep;1(3):397-412
pubmed: 23199084